.Merck beats earnings expectations, raises purchases overview on strong need for best medications like Keytruda CNBCMerck & Co. (MRK United States) Trumps Earnings Projections as Keytruda Sales Rise BloombergMerck Inventory: Pharma Giant Posts Tough End Results, Yet Outlook Falls Short Financier's Organization DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck defeats revenue and also purchases expectations amid Keytruda advantage, but offers mixed full-year overview MarketWatch.